Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human insulin. Its development and clinical use.

E R Ahrens, V V Gossain, D R Rovner

    Postgraduate Medicine
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A proposal for a role of HbA in screening for gestational diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·2009
    Same author

    Patient choice modules for summaries of clinical effectiveness: a proposal.

    BMJ (Clinical research ed.)·2001
    Same author

    Measuring improved patient choice.

    Journal of evaluation in clinical practice·2000
    Same author

    The effects of a low-dose regimen of fosinopril on elevated urinary albumin excretion in normotensive type 1 diabetic patients.

    Journal of medicine·2000
    Same author

    Bone mineral density (BMD) in obesity effect of weight loss.

    Journal of medicine·2000
    Same author

    Patient decision support intervention: increased consistency with decision analytic models.

    Medical care·1999
    Same journal

    CV risk: if you aren't testing ACR, you aren't seeing the full picture.

    Postgraduate medicine·2026
    Same journal

    Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

    Postgraduate medicine·2026
    Same journal

    Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

    Postgraduate medicine·2026
    Same journal

    Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

    Postgraduate medicine·2026
    Same journal

    The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

    Postgraduate medicine·2026
    Same journal

    Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

    Postgraduate medicine·2026
    See all related articles

    Human insulin is now available, marking a new era in diabetes mellitus treatment. While not a cure, it offers potential advantages and lower costs for newly diagnosed insulin-dependent diabetics.

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Metabolic Diseases

    Background:

    • Diabetes mellitus management has evolved with therapeutic advancements.
    • The introduction of human insulin represents a significant development in treatment options.

    Purpose of the Study:

    • To evaluate the implications of human insulin availability in diabetes mellitus therapy.
    • To assess the potential benefits and considerations for using human insulin in clinical practice.

    Main Methods:

    • Review of current literature on human insulin.
    • Analysis of cost-effectiveness compared to other purified insulins.
    • Assessment of known advantages and disadvantages.

    Main Results:

    Related Experiment Videos

  • Human insulin is now available for diabetes mellitus treatment.
  • No disadvantages are currently known.
  • Human insulin is more cost-effective than other purified insulins.

    • Conclusions:

    • Human insulin signifies a new therapeutic era for diabetes mellitus.
    • Its cost-effectiveness and lack of known disadvantages support its consideration for all newly diagnosed insulin-dependent diabetics.